Nuvation Bio
Social media
Nuvation Bio Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Nuvation Bio
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on developing innovative oncology medicines to address unmet needs in cancer treatment. The company develops differentiated and novel therapeutic candidates, including taletrectinib for ROS1+ non-small cell lung cancer, Safusidenib for mutant isocitrate dehydrogenase 1, NUV-1511 for advanced solid tumors, and NUV-868, a selective bromodomain inhibitor. Nuvation Bio aims to improve patient outcomes by targeting drug resistance and limited efficacy of current therapies.
Address
1500 Broadway, Suite 1401
New York, 10036
United States
Year founded
2020
Number of employees
200-300
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add Nuvation Bio logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/nuvationbio.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.